Carbidopa -
Is It Needed
For All?
Peer-reviewed literature documents that 45.3% of patients taking L-dopa experience no nausea.

72.7% DO NOT NEED CARBIDOPA

100% EXPOSED TO CARIBODA INDUCED VITAMIN B6 DEPLETION

WARNINGS --- LODOSYN (Carbidopa) has no antiparkinsonian effect

Carbidopa Ineffective

Carbidopa can deplete vitamin B6.

Depletion Paper #1  Depletion Paper #2  Depletion Paper #3

Since 1999 it has been the standard of care in medicine to give carbidopa with L-dopa. The numbers are as follows.

Peer-reviewed literature documents that 45.3% of patients taking L-dopa experience no nausea.

Carbidopa (Lodosyn) prescribing information as posted by the FDA on its website notes that “…about half of the patients who experience nausea and vomiting when managed only with L-dopa improved spontaneously despite being retained on the same dose of levodopa during the controlled portion of the trial.”

Spontaneous Improvement

When you do the math, 72.7% of patients do not need carbidopa.

The only reason to use carbidopa is whenever unmanageable L-dopa induced nausea is present. But, 100% of patients are receiving this drug which binds irreversibly to vitamin B6 and vitamin B6 enzymes.

  1. 45.3% taking L-dopa have no nausea
  2. 50% with nausea improve spontaneously
  3. 72.7% do not need carbidopa
  4. 100% prescribed L-dopa currently take carbidopa and are exposed to carbidopa problems

Carbidopa can induce:

  • Carbidopa and benserazide prescribing information notes, it can cause dyskinesias.
  • Carbidopa and benserazide irreversibly deplete vitamin B6
  • Carbidopa and benserazide irreversibly deplete vitamin B6 dependent enzymes
  • Carbidopa and benserazide can induce relative nutritional deficiency with symptoms identical to Parkinson’s disease
  • Carbidopa and benserazide may cause the 390% increase in the Parkinson’s death rate since 1976
  • Carbidopa and benserazide vitamin B6 depletion can compromise the function of over 300 enzymes and proteins
  • Carbidopa and benserazide may induce over 100 side effects.
  • Carbidopa and benserazide can collapse dopamine synthesis
  • Carbidopa and benserazide can collapse glutathione synthesis (thiol depletion)
  • Carbidopa and benserazide can collapse serotonin synthesis
  • Carbidopa and benserazide can collapse histamine synthesis
  • Carbidopa and benserazide can collapse phenylethylamine synthesis
  • Carbidopa and benserazide can collapse niacin synthesis
  • Carbidopa and benserazide can collapse norepinephrine synthesis
  • Carbidopa and benserazide can collapse epinephrine (adrenaline) synthesis

For more information on our approach to Parkinson’s disease send an email to info@parkinsonsclinics.com or call 218-626-2220. After you send your email, we may ask for more information. All communications will be kept confidential. If you have any questions, please call us free of charge.

Would you like more information on our unique approach to Parkinson's disease care?